DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Dimethyltryptamine is an investigational drug.
There have been 19 clinical trials for Dimethyltryptamine. The most recent clinical trial was a Phase 2 trial, which was initiated on March 11th 2019.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Depressive Disorder, Major. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and GH Research Limited.
There are one hundred and fifty-eight US patents protecting this investigational drug and nine hundred and ninety-one international patents.
Recent Clinical Trials for Dimethyltryptamine
|Psilocybin Therapy for Depression in Bipolar II Disorder||University of California, San Francisco||Phase 2|
|Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects||Beckley Psytech Limited||Phase 1|
|Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease||Joshua Woolley, MD/PhD||Phase 2|
Top disease conditions for Dimethyltryptamine
Top clinical trial sponsors for Dimethyltryptamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Dimethyltryptamine||⤷ Try it Free||Methods of improving behavioral therapies||Emory University (Atlanta, GA)||⤷ Try it Free|
|Dimethyltryptamine||⤷ Try it Free||Complex and structurally diverse compounds||The Board of Trustees of the University of Illinois (Urbana, IL)||⤷ Try it Free|
|Dimethyltryptamine||⤷ Try it Free||Factor XIa inhibitors||Merck Sharp & Dohme Corp. (Rahway, NJ)||⤷ Try it Free|
|Dimethyltryptamine||⤷ Try it Free||Pharmaceutical compositions resistant to abuse||EGALET LTD. (London, GB)||⤷ Try it Free|
|Dimethyltryptamine||⤷ Try it Free||Formulations of histone deacetylase inhibitor and uses thereof||Pharmacyclics LLC (Sunnyvale, CA)||⤷ Try it Free|
|Dimethyltryptamine||⤷ Try it Free||Methods, devices and systems for pulmonary delivery of active agents||Syqe Medical Ltd. (Tel-Aviv, IL)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Dimethyltryptamine||World Intellectual Property Organization (WIPO)||WO2013142873||2032-03-23||⤷ Try it Free|
|Dimethyltryptamine||European Patent Office||EP3134408||2034-04-22||⤷ Try it Free|
|Dimethyltryptamine||World Intellectual Property Organization (WIPO)||WO2015164308||2034-04-22||⤷ Try it Free|
|Dimethyltryptamine||Australia||AU2010211376||2029-02-06||⤷ Try it Free|
|Dimethyltryptamine||Australia||AU2013257533||2029-02-06||⤷ Try it Free|
|Dimethyltryptamine||Canada||CA2751627||2029-02-06||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|